It has been reported that VEGF signaling enhances the CCM lesion burden in the Ccm1-deficient mice; inhibition of VEGFR2 using a specific inhibitor SU5416 significantly decreased the number of lesions formed and slightly lowered the average lesion size in Ccm1-knockout mice43. The gene discussed is VEGFA; the disease is cerebral cavernous malformation.